Dr. Reddy's to Release Q3 FY15 Results on January 29, 2015

HYDERABAD, India--(BUSINESS WIRE)--

Dr. Reddy's Laboratories RDY will announce results for the Third Quarter ended December 31, 2014 on Thursday, January 29, 2015 after the Board Meeting. The results will be available on the Company's website www.drreddys.com.

Summary of Events

Event			Date and Time			Medium
Release of financial results			January 29th, after the Board Meeting			Email, Media, Company website, Businesswire
Earnings Call			January 29th, 6.30 PM IST / 8:00 AM EST			Hosted by the Company (Details below)
Webcast of Earnings Call			January 29th, 6.30 PM IST / 8.00 AM EST through February 3rd			URL available on Company's website, www.drreddys.com
Transcript of the Earnings call			Will be available on the Company's website			URL available on Company's website, www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company's financial performance.

Conference Dial-In Numbers
Primary Number:			+91 22 3960 0616
Secondary Number:			+91 22 6746 5826
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:			6000 1221 Available in - Ahmedabad, Bangalore, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur, Kolkata, Nagpur, Noida, Patna, Pune, Raipur, Rajkot, Surat, Trivandrum, Vadodara, Vijayawada Accessible from all major carriers except BSNL/MTNL. 3940 3977 Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune Accessible from all carriers.
International Toll Free Number:			USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through February 3rd, 2015. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy's

Dr. Reddy's Laboratories Ltd. RDY is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets.

For more information, log on to: www.drreddys.com